• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.
    All News #Library
    Biotech

    Context` CTIM-76 Gets FDA Fast Track for Ovarian Cancer

    GLOBENEWSWIRE

    Context Therapeutics Reports 2025 Financial Results

    GLOBENEWSWIRE

    Context Therapeutics Joins Investor Conferences

    GLOBENEWSWIRE

    Context Announces Inducement Grants Under Nasdaq LR 5635(c)(4)

    GLOBENEWSWIRE

    Context Therapeutics Showcases CT-95 And CT-202 Programs at SITC

    GLOBENEWSWIRE

    Context Therapeutics Reports Q3 2025 Operating & Financial

    GLOBENEWSWIRE

    Context Therapeutics Joins Investor Conferences

    GLOBENEWSWIRE

    Context Therapeutics Reveal Inducement Under Nasdaq LR 5635(c)(4)

    GLOBENEWSWIRE

    Context Therapeutics Announces CTIM-76 Trial Poster at 2025 ASCO

    GLOBENEWSWIRE

    Context Therapeutics Reports Q1 2025 Results

    GLOBENEWSWIRE

    Context Therapeutics Doses First Patient in CT-95 Phase 1 Trial

    GLOBENEWSWIRE

    Integral Molecular`s Bispecific Antibody Enters Clinical Trial fo

    PR NEWSWIRE

    Context Therapeutics Doses First Patient In CTIM-76 Phase 1 Trial

    GLOBENEWSWIRE

    Context Therapeutics Reports Q3 2024 Operating & Financial Results

    GLOBENEWSWIRE

    Context Therapeutics Announces Poster Presentation At SITC Meeting

    GLOBENEWSWIRE

    BioAtla Context License BA3362 Nectin-4 x CD3 T Cell Antibody

    GLOBENEWSWIRE

    Context builds bispecific bank with $133M biobucks deal

    FIERCE BIOTECH

    Context Announces FDA Clearance of IND Application for a Phase 1 of CTIM-76

    GLOBENEWSWIRE

    Context Submits IND App to Evaluate CTIM-76 in Claudin 6-Positive Cancers

    GLOBENEWSWIRE

    Context Announces Data Demonstrating Active Profile of CTIM-76

    GLOBENEWSWIRE

    Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.